Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.080 | 0.875 | 8 | 2011 | 2019 | ||||
Carcinoma of lung
|
1204 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.070 | 0.857 | 7 | 2003 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.070 | 0.857 | 7 | 2003 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.070 | 0.857 | 7 | 2003 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.060 | 1.000 | 6 | 2008 | 2016 | ||||
Malignant neoplasm of breast
|
3417 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.060 | 1.000 | 6 | 2008 | 2016 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.060 | 0.833 | 6 | 2014 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.050 | 0.800 | 5 | 2009 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Stomach Carcinoma
|
652 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.050 | 0.800 | 5 | 2009 | 2018 | ||||
Xeroderma pigmentosum, group G
|
31 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.040 | 1.000 | 4 | 2014 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.030 | 1.000 | 3 | 2011 | 2014 | ||||
Bladder Neoplasm
|
281 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 0.500 | 2 | 2011 | 2014 | ||||
Carcinoma of bladder
|
309 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 0.500 | 2 | 2011 | 2014 | ||||
Carcinoma of larynx
|
65 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Childhood Osteosarcoma
|
151 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Glioma
|
353 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2017 | 2017 | ||||
Malignant neoplasm of larynx
|
50 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2012 | 2017 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 0.500 | 2 | 2011 | 2014 | ||||
melanoma
|
515 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2011 | 2015 | ||||
Osteosarcoma
|
178 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Osteosarcoma of bone
|
151 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Prostate carcinoma
|
1168 | 0.597 | 0.560 | 13 | 102875652 | missense variant | G/C | snv | 0.28 | 0.30 | 0.020 | 1.000 | 2 | 2012 | 2017 |